Sage Mountain Advisors LLC Sells 870 Shares of Kenvue Inc. (NYSE:KVUE)

Sage Mountain Advisors LLC lowered its stake in shares of Kenvue Inc. (NYSE:KVUE) by 7.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 10,807 shares of the company’s stock after selling 870 shares during the quarter. Sage Mountain Advisors LLC’s holdings in Kenvue were worth $233,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of KVUE. CWM LLC increased its position in shares of Kenvue by 1,521.1% during the 3rd quarter. CWM LLC now owns 12,969 shares of the company’s stock valued at $260,000 after purchasing an additional 12,169 shares during the last quarter. AE Wealth Management LLC bought a new position in shares of Kenvue during the 3rd quarter valued at approximately $619,000. AdvisorNet Financial Inc bought a new position in Kenvue in the 3rd quarter valued at $28,000. IFP Advisors Inc bought a new position in Kenvue in the 3rd quarter valued at $38,000. Finally, Global Retirement Partners LLC bought a new position in Kenvue in the 3rd quarter valued at $28,000. Institutional investors own 97.64% of the company’s stock.

Kenvue Price Performance

Shares of NYSE KVUE opened at $19.59 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.78 and a current ratio of 1.12. Kenvue Inc. has a 1-year low of $17.82 and a 1-year high of $27.80. The business has a fifty day moving average price of $19.84 and a 200 day moving average price of $20.16.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, February 8th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.03. The firm had revenue of $3.67 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. Kenvue’s revenue for the quarter was down 2.7% compared to the same quarter last year. Research analysts anticipate that Kenvue Inc. will post 1.15 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.08%. The ex-dividend date was Tuesday, February 13th.

Analyst Upgrades and Downgrades

KVUE has been the topic of several research analyst reports. William Blair initiated coverage on Kenvue in a research report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. Sanford C. Bernstein initiated coverage on Kenvue in a research report on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price objective on the stock. Royal Bank of Canada cut their price objective on Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, February 9th. The Goldman Sachs Group began coverage on Kenvue in a research report on Friday, March 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. Finally, JPMorgan Chase & Co. dropped their price target on Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a research report on Friday, February 9th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $24.85.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.